Academic Psychiatry

, Volume 29, Issue 1, pp 33–39 | Cite as

Attitudes and Behaviors of Psychiatry Residents Toward Pharmaceutical Representatives Before and After an Educational Intervention

  • Melinda L. Randall
  • Julie R. Rosenbaum
  • Robert M. Rohrbaugh
  • Robert A. Rosenheck
Original Article


Objective: The authors sought to determine the effect of an educational seminar on interactions with pharmaceutical representatives on residents’ attitudes and behavior. Method: A controlled trial of an educational intervention was conducted. Residents at a university-affiliated residency program (N=32) were divided into two groups: one group (N=18) received a 1-hour educational intervention, while the other group (N= 14) served as a control. Both groups completed a 33-item survey before the intervention and 2 months after the intervention. Results: Residents interacted substantially with pharmaceutical representatives. The majority of residents found the interactions and gifts useful and believed their prescribing practices were not influenced. Compared to the comparison group, the intervention group significantly decreased the reported number of office supplies and noneducational gifts, but showed no change in attitude toward pharmaceutical representatives and their gifts. Conclusion: One-time educational interventions may have significant impact on psychiatric residents’ targeted gift-accepting behavior but little effect on attitudes.


Educational Intervention Residency Program Academic Psychiatry Psychiatry Resident Internal Medicine Resident 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Wazana A: Physicians and the pharmaceutical industry: is a gift ever just a gift? [see comments]. JAMA 2000; 283: 373–380PubMedCrossRefGoogle Scholar
  2. 2.
    Smith MC: Drug product advertising and prescribing: a review of the evidence. Am J Hosp Pharm 1977; 34: 1208–1224PubMedGoogle Scholar
  3. 3.
    Lexchin J: Interactions between physicians and the pharmaceutical industry: what does the literature say? Can Med Assoc J 1993; 149: 1401–1407Google Scholar
  4. 4.
    Hemminki E: Review of literature on the factors affecting drug prescribing. Soc Sci Med 1975; 9: 111–116PubMedCrossRefGoogle Scholar
  5. 5.
    Schwartz TL, Kuhles DJ 2nd, Wade M, Masand PS: Newly admitted psychiatric patient prescriptions and pharmaceutical sales visits. Ann Clin Psychiatry 2001; 13: 159–162PubMedCrossRefGoogle Scholar
  6. 6.
    AMA: Current opinions. AMA policy compendium 1999Google Scholar
  7. 7.
    America PRaMo: PhRMA Code on Interactions with Healthcare Professionals, 2002, pp 1–9Google Scholar
  8. 8.
    General OoI: Compliance Program Guidance for Pharmaceutical Manufacturers, 2003, pp 13–38Google Scholar
  9. 9.
    Hodges B: Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks. Can Med Assoc J 1995; 153: 553–559Google Scholar
  10. 10.
    McKinney WP, Schiedermayer DL, Lurie N, Simpson DE, Goodman JL, Rich EC: Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales representatives. JAMA 1990; 264: 1693–1697PubMedCrossRefGoogle Scholar
  11. 11.
    Sergeant MD, Hodgetts PG, Godwin M, Walker DM, McHenry P: Interactions with the pharmaceutical industry: a survey of family medicine residents in Ontario. Can Med Assoc J 1996; 155: 1243–1248Google Scholar
  12. 12.
    Lichstein PR, Turner RC, O’Brien K: Impact of pharmaceutical company representatives on internal medicine residency programs: a survey of residency program directors. Arch Intern Med 1992; 152: 1009–1013PubMedCrossRefGoogle Scholar
  13. 13.
    Brotzman GL, Mark DH: The effect on resident attitudes of regulatory policies regarding pharmaceutical representative activities. J Gen Intern Med 1993; 8: 130–134PubMedCrossRefGoogle Scholar
  14. 14.
    Shaughnessy AF, Slawson DC, Bennett JH: Teaching information mastery: evaluating information provided by pharmaceutical representatives. Fam Med 1995; 27: 581–585PubMedGoogle Scholar
  15. 15.
    Hopper JA, Speece MW, Musial JL: Effects of an educational intervention on residents’ knowledge and attitudes toward interactions with pharmaceutical representatives. J Gen Intern Med 1997; 12: 639–642PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.
    Waud DR: Pharmaceutical promotions—a free lunch? N Engl J Med 1992; 327: 351–353PubMedCrossRefGoogle Scholar
  17. 17.
    Howard SM: Gifts to physicians from the pharmaceutical industry [comment]. JAMA 2000; 283: 2655–2666; discussion 2657–2658PubMedCrossRefGoogle Scholar
  18. 18.
    Shaughnessy AF, Slawson DC, Bennett JH: Separating the wheat from the chaff: identifying fallacies in pharmaceutical promotion. J Gen Intern Med 1994; 9: 563–568PubMedCrossRefGoogle Scholar
  19. 19.
    Steinman MA, Shlipak MG, McPhee SJ: Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions. Am J Med 2001; 110: 551–557PubMedCrossRefGoogle Scholar

Copyright information

© Academic Psychiatry 2005

Authors and Affiliations

  • Melinda L. Randall
    • 1
  • Julie R. Rosenbaum
    • 2
  • Robert M. Rohrbaugh
    • 1
  • Robert A. Rosenheck
    • 1
  1. 1.Department of PsychiatryVACHSWest HavenUSA
  2. 2.Department of Primary CareYale UniversityWaterburyUSA

Personalised recommendations